Pei‐Hua Peng

749 total citations
24 papers, 535 citations indexed

About

Pei‐Hua Peng is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Pei‐Hua Peng has authored 24 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Pei‐Hua Peng's work include Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (10 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Pei‐Hua Peng is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (10 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Pei‐Hua Peng collaborates with scholars based in Taiwan, China and United States. Pei‐Hua Peng's co-authors include Kai‐Wen Hsu, Kou‐Juey Wu, Ziyang Hao, Chuan He, Xiaolong Cui, Allen Zhu, Lisheng Zhang, Jianzhao Liu, Lulu Hu and Yawei Gao and has published in prestigious journals such as Nucleic Acids Research, Molecular Cell and Analytical Chemistry.

In The Last Decade

Pei‐Hua Peng

22 papers receiving 527 citations

Peers

Countries citing papers authored by Pei‐Hua Peng

Since Specialization

Citations

This map shows the geographic impact of Pei‐Hua Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei‐Hua Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei‐Hua Peng more than expected).

Fields of papers citing papers by Pei‐Hua Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pei‐Hua Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei‐Hua Peng. The network helps show where Pei‐Hua Peng may publish in the future.

Co-authorship network of co-authors of Pei‐Hua Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Pei‐Hua Peng. A scholar is included among the top collaborators of Pei‐Hua Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pei‐Hua Peng. Pei‐Hua Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integration of the cancer cell secretome and transcriptome reveals potential noninvasive diagnostic markers for bladder cancer 2024 ·PROTEOMICS - CLINICAL APPLICATIONS ·Yi‐Ting Chen, (unknown), (unknown), Chih‐Ching Wu, Shir‐Hwa Ueng, Kai‐Jie Yu, Chien‐Lun Chen, Pei‐Hua Peng, Jau‐Song Yu, (unknown)	2
2	ALKBH4 functions as a hypoxia-responsive tumor suppressor and inhibits metastasis and tumorigenesis 2024 ·Cellular Oncology ·Ji‐Lin Chen, Pei‐Hua Peng, Han‐Tsang Wu, Dar‐Ren Chen, Ching-Yun Hsieh, (unknown), Joseph Lin, (unknown), Kai‐Wen Hsu	0
3	PLK1 and its substrate MISP facilitate intrahepatic cholangiocarcinoma progression by promoting lymphatic invasion and impairing E-cadherin adherens junctions 2023 ·Cancer Gene Therapy ·(unknown), (unknown), Wen‐Kuan Huang, Pei‐Hua Peng, Shih‐Ming Jung, Sheng‐Hsuan Lin, (unknown), Chiao‐En Wu, (unknown), Alice L. Yu, Kou‐Juey Wu, Chun‐Nan Yeh	2
4	RP11‐367G18.1 V2 enhances clear cell renal cell carcinoma progression via induction of epithelial–mesenchymal transition 2023 ·Cancer Medicine ·I‐Hung Shao, Pei‐Hua Peng, Heng‐Hsiung Wu, Ji‐Lin Chen, (unknown), (unknown), Han‐Tsang Wu, Kou‐Juey Wu, See‐Tong Pang, Kai‐Wen Hsu	7
5	Interplay between lncRNA RP11-367G18.1 variant 2 and YY1 plays a vital role in hypoxia-mediated gene expression and tumorigenesis 2023 ·Cancer Cell International ·Pei‐Hua Peng, Ji‐Lin Chen, Heng‐Hsiung Wu, Wenhao Yang, (unknown), (unknown), (unknown), (unknown), Han‐Tsang Wu, Fei‐Ting Hsu, Wei‐Chung Cheng, Kai‐Wen Hsu	3
6	Epigenetic regulation of asymmetric cell division by the LIBR-BRD4 axis 2023 ·Nucleic Acids Research ·Hsiao‐Fan Chen, (unknown), Kai‐Wen Hsu, Pei‐Hua Peng, (unknown), Mien‐Chie Hung, Kou‐Juey Wu	4
7	Biliverdin modulates the long non-coding RNA H19/microRNA-181b-5p/endothelial cell specific molecule 1 axis to alleviate cerebral ischemia reperfusion injury 2022 ·Biomedicine & Pharmacotherapy ·Junjie Li, Haiyan Jiang, Pei‐Hua Peng, Qi Zhang, (unknown), (unknown), (unknown), (unknown), Jianlin Shao	11
8	METTL4-mediated nuclear N6-deoxyadenosine methylation promotes metastasis through activating multiple metastasis-inducing targets 2022 ·Genome biology ·Kai‐Wen Hsu, (unknown), (unknown), Pei‐Hua Peng, Ching-Hui Huang, Der‐Yen Lee, Yu‐Cheng Tsai, Chi‐Jung Chung, (unknown), (unknown), Ji‐Lin Chen, See‐Tong Pang, Ziyang Hao, Xiaolong Cui, Chuan He, Kou‐Juey Wu	29
9	Using bioinformatics approaches to identify survival-related oncomiRs as potential targets of miRNA-based treatments for lung adenocarcinoma 2022 ·Computational and Structural Biotechnology Journal ·Chia-Hsin Liu, Shu‐Hsuan Liu, (unknown), (unknown), George T.Y. Chen, (unknown), Pei‐Hua Peng, Chia‐Yang Li, Shu‐Chi Wang, Ji‐Lin Chen, Heng‐Hsiung Wu, Min-Zu Wu, Yuh‐Pyng Sher, Wei‐Chung Cheng, Kai‐Wen Hsu	2
10	Chromatin accessibility analysis identifies GSTM1 as a prognostic marker in human glioblastoma patients 2021 ·Clinical Epigenetics ·Yin-Cheng Huang, (unknown), Pei‐Hua Peng, Kuo‐Chen Wei, Kou‐Juey Wu	3
11	The role of hypoxia-induced long noncoding RNAs (lncRNAs) in tumorigenesis and metastasis 2021 ·Biomedical Journal ·Pei‐Hua Peng, Kai‐Wen Hsu, (unknown), Kou‐Juey Wu	22
12	Biliverdin Protects Against Cerebral Ischemia/Reperfusion Injury by Regulating the miR-27a-3p/Rgs1 Axis 2021 ·Neuropsychiatric Disease and Treatment ·Junjie Li, (unknown), (unknown), Pei‐Hua Peng, Wendong Chen, Wei Yang, Jianlin Shao	14
13	Scutellarin Reduces Cerebral Ischemia Reperfusion Injury Involving in Vascular Endothelium Protection and PKG Signal 2021 ·Natural Products and Bioprospecting ·Yajuan Chen, Chen Chen, Mengyuan Li, Qingqing Li, Xiujuan Zhang, Rong Huang, (unknown), (unknown), Liuyi Zhang, Pei‐Hua Peng, Weimin Yang	8
14	Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach 2020 ·Scientific Reports ·(unknown), (unknown), Pei-Chun Shen, George T.Y. Chen, (unknown), Heng‐Hsiung Wu, Pei‐Hua Peng, Kai‐Wen Hsu, Wei‐Chung Cheng	15
15	N6-Deoxyadenosine Methylation in Mammalian Mitochondrial DNA 2020 ·Molecular Cell ·Ziyang Hao, Tong Wu, Xiaolong Cui, Pingping Zhu, Cai‐Ping Tan, Xiaoyang Dou, Kai‐Wen Hsu, Yueh‐Te Lin, Pei‐Hua Peng, Lisheng Zhang, Yawei Gao, Lulu Hu, Hui‐Lung Sun, Allen Zhu, Jianzhao Liu, Kou‐Juey Wu, Chuan He	182
16	Effect of goal-directed fluid therapy on postoperative rehabilitation in elderly patients undergoing resection of gastrointestinal tumor 2015 ·Zhonghua mazuixue zazhi ·(unknown), (unknown), Pei‐Hua Peng, Wendong Chen, Junming Li, (unknown), Haiyan Jiang	1
17	Identification of secretory gelsolin as a plasma biomarker associated with distant organ metastasis of colorectal cancer 2011 ·Journal of Molecular Medicine ·Ming‐Hung Tsai, Chih‐Ching Wu, Pei‐Hua Peng, Ying Liang, Yen-Chang Hsiao, Kun‐Yi Chien, (unknown), (unknown), Reiping Tang, Ling‐Ling Hsieh, Jau‐Song Yu	28
18	Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: Potential usage of cystatin A for predicting nodal stage and poor prognosis 2010 ·PROTEOMICS ·Kai‐Ping Chang, Chih‐Ching Wu, Hua‐Chien Chen, Shu‐Jen Chen, Pei‐Hua Peng, Ngan‐Ming Tsang, Li‐Yu Lee, (unknown), Ying Liang, Yun‐Shien Lee, Sheng‐Po Hao, Yu‐Sun Chang, Jau‐Song Yu	44
19	Identification of potential serum markers for nasopharyngeal carcinoma from a xenografted mouse model using Cy‐dye labeling combined with three‐dimensional fractionation 2008 ·PROTEOMICS ·Chih‐Ching Wu, Pei‐Hua Peng, Ya‐Ting Chang, (unknown), Kai‐Ping Chang, Sheng‐Po Hao, Ngan‐Ming Tsang, Chau‐Ting Yeh, Yu‐Sun Chang, Jau‐Song Yu	26
20	Genomic and cDNA Cloning, Characterization ofDelonix regiaTrypsin Inhibitor (DrTI) Gene, and Expression of DrTI inEscherichia coli 2007 ·Bioscience Biotechnology and Biochemistry ·Chih-Hung Hung, Pei‐Hua Peng, (unknown), (unknown), Yu-Jen Chen, Yuanliang Chen, Lang‐Ming Chi	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact